go back

Idecabtagene Vicleucel (Abecma), up to 460 Million Cells

Kentucky rates for HCPCS C9081

Idecabtagene vicleucel, up to 460 million autologous anti-BCMA CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

How much rates vary

Facilitymedian $52,481 · 10th to 90th $41,687 to $56,234Professionalmedian $426,580 · 10th to 90th $46,774 to $426,580
$50K$100K$200Kfacility $52,481professional $426,580

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Small sample; interpret with caution. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
CareSource
Setting
Facility
Modifier
Global
Typical Low
$41,686.94
Median
$52,480.75
Typical High
$56,234.13
CareSource
Setting
Professional
Modifier
Global
Typical Low
$46,773.51
Median
$426,579.52
Typical High
$426,579.52